Emmanuel Chantelot
About Emmanuel Chantelot
Emmanuel Chantelot is the Vice President, Head of International Policy & Government Affairs at Bristol Myers Squibb, with extensive experience in government relations and policy across the pharmaceutical industry.
Title and Current Position
Emmanuel Chantelot currently serves as the Vice President, Head of International Policy & Government Affairs at Bristol Myers Squibb. Operating out of the Brussels Metropolitan Area, he leads the company's international policy and government affairs initiatives, contributing his extensive expertise to drive policy developments and advocacy.
Previous Roles at Bristol Myers Squibb
Prior to his current role, Emmanuel Chantelot was the Executive Director, Head of Policy & Government Affairs, Major Markets / Europe at Bristol Myers Squibb from 2019 to 2022. During his tenure in Brussels, Belgium, he focused on policy leadership and government relations across major European markets.
Experience at Celgene
Emmanuel Chantelot worked at Celgene in several key positions. From 2018 to 2019, he was the Executive Director, Head of Government Relations & Policy Worldwide Markets in Brussels, Belgium, and Boudry, Switzerland. Additionally, he served as Executive Director, Head of Government Relations and Policy, Europe from 2016 to 2018, where he focused on European government relations and policy strategies.
Roles at Shire Pharmaceuticals
At Shire Pharmaceuticals, Emmanuel held the role of Senior Director, Head of International Government Relations and Public Affairs from 2013 to 2016. He also served as the Senior Director, Head of European Government Relations and Public Policy from 2011 to 2013. His responsibilities included managing government relations and public affairs in both European and global markets, operating from Brussels, Belgium, Zug, Switzerland, and Nyon, Switzerland.
Involvement with Industry Associations
Emmanuel Chantelot has been actively involved with various industry associations. He was the Chairman of EuropaBio's Healthcare Biotechnology Council from 2013 to 2015, contributing significantly to healthcare biotechnology policies. He also served as Executive Director of the European Biopharmaceutical Enterprises from 2006 to 2011, influencing biopharmaceutical policies and industry standards.
Educational Background
Emmanuel Chantelot holds a Master’s degree from Vrije Universiteit Brussel, completed in 1992, and another Master’s degree from Université libre de Bruxelles, achieved in 1991. He also studied at Northwestern University's Kellogg School of Management in 2002, enhancing his expertise in management and leadership.